Predictive Oncology (POAI) Institutional Ownership → Millionaire Investor makes surprising election prediction (From InvestorPlace) (Ad) Free POAI Stock Alerts $1.68 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Predictive Oncology (NASDAQ:POAI)CurrentInstitutional OwnershipPercentage9.04%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$412.41KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.88M Get POAI Insider Trade Alerts Want to know when executives and insiders are buying or selling Predictive Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data POAI Institutional Buying and Selling by Quarter Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Predictive Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024 Carnegie Mellon University10,358$34K0.0%N/A0.255% 10/24/2023 Raymond James & Associates118,229$378K0.0%N/A2.934% 8/8/2023 RB Capital Management LLC20,835$101K0.0%-95.0%0.525% 8/1/2023 Carnegie Mellon University10,358$50K0.1%-95.0%0.261% 5/10/2023 RB Capital Management LLC416,693$136K0.0%+161.2%10.496% 2/6/2023 Sax Wealth Advisors LLC147,437$45K0.0%+37.2%0.187% Get the Latest News and Ratings for POAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022 Sax Wealth Advisors LLC107,437$44K0.0%N/A0.162% 7/14/2022 RB Capital Management LLC159,500$65K0.0%N/A0.241% 11/9/2021 BlackRock Inc.160,629$214K0.0%+12.9%0.246% 8/17/2021 Price T Rowe Associates Inc. MD106,200$139K0.0%N/A0.162% 8/16/2021 State Street Corp298,632$391K0.0%N/A0.457% 8/13/2021 Geode Capital Management LLC414,705$543K0.0%+198.4%0.635% 8/13/2021 Vanguard Group Inc.1,838,085$2.41M0.0%+231.9%2.813% 8/12/2021 Private Advisor Group LLC26,805$35K0.0%+84.0%0.041% 5/19/2021Virtu Financial LLC82,810$100K0.0%N/A0.166% 5/17/2021 Armistice Capital LLC2,051,284$2.48M0.1%N/A4.117% 5/17/2021 Goldman Sachs Group Inc.164,258$199K0.0%N/A0.330% 5/13/2021 Renaissance Technologies LLC593,267$718K0.0%N/A1.191% 5/13/2021 Bank of New York Mellon Corp37,348$45K0.0%N/A0.075% 5/12/2021 Northern Trust Corp67,289$81K0.0%+343.4%0.135% 5/12/2021 Geode Capital Management LLC138,973$168K0.0%N/A0.279% 5/11/2021Maryland Capital Management46,000$56K0.0%N/A0.092% 8/14/2020 Sabby Management LLC223,540$367K0.1%N/A1.541% 8/12/2020 Bank of New York Mellon Corp49,449$81K0.0%+191.7%0.341% 8/7/2020Virtu Financial LLC22,668$37K0.0%N/A0.156% 7/17/2020 Csenge Advisory Group17,500$29K0.0%N/A0.133% 5/6/2020 Bank of New York Mellon Corp16,953$27K0.0%N/A0.274% (Data available from 1/1/2016 forward) POAI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of POAI shares? During the previous two years, the following institutional investors and hedge funds held shares of Predictive Oncology shares: Raymond James & Associates ($378K), RB Capital Management LLC ($101K), and Sax Wealth Advisors LLC ($45K), Carnegie Mellon University ($34K).Learn more on POAI's institutional investors. What percentage of Predictive Oncology stock is owned by institutional investors? 9.04% of Predictive Oncology stock is owned by institutional investors. Learn more on POAI's institutional investor holdings. Which institutional investors have been buying Predictive Oncology stock? The following institutional investors have purchased Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($416.69K), Sax Wealth Advisors LLC ($147.44K), Raymond James & Associates ($118.23K), and Carnegie Mellon University ($10.36K). How much institutional buying is happening at Predictive Oncology? Institutional investors have bought a total of 692,717 shares in the last 24 months. This purchase volume represents approximately $4.53M in transactions. Which Predictive Oncology major shareholders have been selling company stock? The following institutional investors have sold Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($395.86K), and Carnegie Mellon University ($196.79K). How much institutional selling is happening at Predictive Oncology? Institutional investors have sold a total of 592,644 shares in the last 24 months. This volume of shares sold represents approximately $2.88M in transactions. Related Companies: Heart Test Laboratories Institutional Ownership NanoVibronix Institutional Ownership Hepion Pharmaceuticals Institutional Ownership Cadrenal Therapeutics Institutional Ownership Virios Therapeutics Institutional Ownership Vaccinex Institutional Ownership eFFECTOR Therapeutics Institutional Ownership Vivos Therapeutics Institutional Ownership Intelligent Bio Solutions Institutional Ownership iBio Institutional Ownership This page (NASDAQ:POAI) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceNext President (Not Trump. Not Biden.)The Freeport SocietyWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.